Miss Betty Jen-Hsing Shih

Selected publications and creative works (Research Outputs)

  • Tran, B. K., Shih, J. H., Wang, Q., Jamieson, S., Print, C. G., Tsai, P. S., ... Buchanan, C. M. (2018). Co-targeting BRAF and VEGF-A receptors synergistically inhibited the growth of BRAF-mutant and BRAF wild-type melanomas. Paper presented at New Zealand Society for Oncology Conference, Queenstown, New Zealand. 24 August - 25 August 2018.
    Other University of Auckland co-authors: Khanh Tran, Claire Wang, Stephen Jamieson, Cristin Print, Peter Tsai, Cherie Blenkiron, Christina Buchanan
  • Sorrenson, B. (2017). The importance of beta-catenin to beta-cell function. Paper presented at 12th Asia Pacific Diabetes and Obesity Symposium (APDO), Hong Kong. 21 October - 22 October 2017.
    Other University of Auckland co-authors: Brie Sorrenson, Kate Lee
  • Sorrenson, B. (2017). PAK kinase in regulation of beta-catenin. Paper presented at Queenstown Research Week: Cell Signalling Satellite, Queenstown, New Zealand. 7 September - 8 September 2017.
    Other University of Auckland co-authors: Brie Sorrenson, Waruni Dissanayake
  • Shih, J. (2012). Evaluation of DMXAA and Analogues Against Putative Targets and Signalling Pathways The University of Auckland. ResearchSpace@Auckland.
    URL: http://hdl.handle.net/2292/13236
  • Buchanan, C. M., Shih, J. H., Rewcastle, G. W., Astin, J. W., Flanagan, J. U., Crosier, P. S., & Shepherd, P. R. (2012). DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGF-R2 in particular. Clinical Science, 122, 449-457. 10.1042/CS20110412
    URL: http://hdl.handle.net/2292/10722
    Other University of Auckland co-authors: Gordon Rewcastle, Christina Buchanan, Jonathan Astin, Jack Flanagan, Peter Shepherd

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 2, Room 228
New Zealand